PATENT CLAIM ANALYSIS

Application Number: 15887289
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "171000"]

Abstract:
The invention relates to the combined use of at least one monoterpene which can be applied systemically, in particular perorally, and at least one respiratory tract therapeutic agent which can be applied topically, in particular through inhalation, for the prophylactic and/or therapeutic treatment, in particular combination therapy and/or co-medication, of respiratory tract diseases, in particular bronchopulmonary diseases. Through the combined use of the systemic monoterpene with the topical, in particular inhaled respiratory tract therapeutic agent, the effect or efficiency of the topical or inhaled respiratory disease therapeutic agent can be increased significantly, in particular in a synergistic manner, on the one hand, and the required dosage thereof can be reduced significantly on the other hand, combined with the resulting advantages (e.g., avoidance or reduction of side effects).

Claim (Index 10):
The method as claimed in  claim 1 ,\n wherein the bronchopulmonary disorder is a chronic obstructive pulmonary disorder (COPD), a chronic obstructive bronchitis or a pulmonary emphysema.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 2.10145
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13587752', '12487563', '12090477', '12850318', '11376615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7645563192143751
- 35 USC 102 Novelty (BERT): 0.4607946389029984
- Combined Prediction Score: 0.7341801511832374
- Mean Citation Score: 157.89303600000005
- Max Citation Score: 182.36914
- Similarity Product: 159.61568417774083

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test